Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  IQVIA Holdings Inc.    IQV

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/14/2020 10/15/2020 10/16/2020 10/19/2020 10/20/2020 Date
165.89(c) 162(c) 164.56(c) 164.05(c) 173.5(c) Last
771 519 1 173 588 1 047 542 1 361 330 2 158 941 Volume
-0.42% -2.34% +1.58% -0.31% +5.76% Change
More quotes
Financials (USD)
Sales 2020 11 208 M - -
Net income 2020 339 M - -
Net Debt 2020 10 450 M - -
P/E ratio 2020 103x
Yield 2020 -
Sales 2021 12 556 M - -
Net income 2021 715 M - -
Net Debt 2021 10 304 M - -
P/E ratio 2021 46,5x
Yield 2021 -
Capitalization 33 260 M 33 260 M -
EV / Sales 2020 3,90x
EV / Sales 2021 3,47x
Nbr of Employees 68 000
Free-Float 74,5%
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions,... 
More about the company
Notations Surperformance© of IQVIA Holdings Inc.
Trading Rating : Investor Rating :
More Ratings
All news about IQVIA HOLDINGS INC.
10/20IQVIA : 3Q Earnings Snapshot
AQ
10/20IQVIA HOLDINGS INC. : Results of Operations and Financial Condition, Financial S..
AQ
10/20IQVIA : Reports Third-Quarter 2020 Results, Raises Full-Year 2020 Guidance and P..
BU
10/15IQVIA HOLDINGS INC. : quaterly earnings release
10/12IQVIA : Joins FDA to Advance COVID-19 Understanding at Community Level through C..
BU
10/07IQVIA : to Announce Third-Quarter Results on October 20, 2020
BU
10/06IQVIA INSTITUTE FOR HUMAN DATA SCIEN : Biosimilars Reach Inflection Point &ndash..
BU
10/05IQVIA : and Medvarsity Collaborate to Provide Flexible Medical Training Solution..
PU
09/14IQVIA : 's eCOA Solution Receives 2020 Fierce Innovation Award
BU
09/01FACTBOX : AstraZeneca's potential coronavirus vaccine
RE
08/31IQVIA : 's RIM Smart Honored as Gold Stevie® Award Winner in 2020 American Busin..
BU
08/06FACTBOX : AstraZeneca's potential coronavirus vaccine
RE
08/05IQVIA : 's Nancy Dreyer and Deepa Desai Honored with 2020 PharmaVOICE Awards
BU
08/04IQVIA : Drug Prices Have Become More Affordable to Most Patients, says U.S. Medi..
BU
07/29IQVIA : Launches OCE Optimizer to Help Intelligently Plan HCP Engagements and Ma..
BU
More news
News in other languages on IQVIA HOLDINGS INC.
10/15Corona-Krise wirbelt den Apothekenmarkt weiter durcheinander
10/15ANALYSTEN :  Versandapotheken haben Marktanteil in der Krise gesteigert
10/15IQVIA HOLDINGS INC. : Veröffentlichung des Quartalsergebnisses
10/15IQVIA HOLDINGS INC. : publication des résultats trimestriels
08/17AUSBLICK ALCON : Q2-Umsatz von 1,2 Milliarden US-Dollar erwartet
More news
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Average target price 189,85 $
Last Close Price 173,50 $
Spread / Highest target 30,8%
Spread / Average Target 9,42%
Spread / Lowest Target -20,5%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
James Grant Berkshire Senior Vice President-Business Operations
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
John M. Leonard Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.12.29%33 260
LONZA GROUP AG64.78%47 655
SEAGEN INC.73.31%34 455
CELLTRION, INC.35.64%28 816
MODERNA, INC.264.57%28 138
IMMUNOMEDICS, INC.314.56%20 291